Rodent antibodies, particularly those derived from mouse and rat hybridomas, remain the cornerstone of therapeutic antibody development, diagnostic assay design, and fundamental research. Securing the precise amino acid sequence of your critical rodent antibody is the ultimate form of biological insurance.